BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21612915)

  • 1. A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up.
    Livingstone E; Windemuth-Kieselbach C; Eigentler TK; Rompel R; Trefzer U; Nashan D; Rotterdam S; Ugurel S; Schadendorf D
    Eur J Cancer; 2011 Sep; 47(13):1977-89. PubMed ID: 21612915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of follow-up in melanoma patients in Germany - results of a multicentre and longitudinal study.
    Livingstone E; Krajewski C; Eigentler TK; Windemuth-Kieselbach C; Benson S; Elsenbruch S; Hauschild A; Rompel R; Meiss F; Mauerer A; Kähler KC; Dippel E; Möllenhoff K; Kilian K; Mohr P; Utikal J; Schadendorf D
    Eur J Cancer; 2015 Mar; 51(5):653-67. PubMed ID: 25638778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V; Breuninger H; Garbe C; Moehrle M
    Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France.
    Grange F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A
    Arch Dermatol; 2008 May; 144(5):629-36. PubMed ID: 18490589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of melanoma with regional lymph node metastases: a population-based study in France.
    Lévy-Sitbon C; Barbe C; Granel-Brocard F; Lipsker D; Aubin F; Dalac S; Truchetet F; Michel C; Mitschler A; Arnoult G; Le Clainche A; Dalle S; Bernard P; Grange F
    J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1081-7. PubMed ID: 22845015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".
    Pflugfelder A; Kochs C; Blum A; Capellaro M; Czeschik C; Dettenborn T; Dill D; Dippel E; Eigentler T; Feyer P; Follmann M; Frerich B; Ganten MK; Gärtner J; Gutzmer R; Hassel J; Hauschild A; Hohenberger P; Hübner J; Kaatz M; Kleeberg UR; Kölbl O; Kortmann RD; Krause-Bergmann A; Kurschat P; Leiter U; Link H; Loquai C; Löser C; Mackensen A; Meier F; Mohr P; Möhrle M; Nashan D; Reske S; Rose C; Sander C; Satzger I; Schiller M; Schlemmer HP; Strittmatter G; Sunderkötter C; Swoboda L; Trefzer U; Voltz R; Vordermark D; Weichenthal M; Werner A; Wesselmann S; Weyergraf AJ; Wick W; Garbe C; Schadendorf D; ;
    J Dtsch Dermatol Ges; 2013 Aug; 11 Suppl 6():1-116, 1-126. PubMed ID: 24028775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance with guidelines in the surgical management of cutaneous melanoma across the USA.
    Wasif N; Gray RJ; Bagaria SP; Pockaj BA
    Melanoma Res; 2013 Aug; 23(4):276-82. PubMed ID: 23695440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.
    Bilimoria KY; Balch CM; Wayne JD; Chang DC; Palis BE; Dy SM; Lange JR
    J Clin Oncol; 2009 Apr; 27(11):1857-63. PubMed ID: 19273706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Completion node dissection in patients with sentinel node-positive melanoma of the head and neck.
    Smith VA; Cunningham JE; Lentsch EJ
    Otolaryngol Head Neck Surg; 2012 Apr; 146(4):591-9. PubMed ID: 22237296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive features of melanoma and its management in elderly patients: a population-based study in France.
    Ciocan D; Barbe C; Aubin F; Granel-Brocard F; Lipsker D; Velten M; Dalac S; Truchetet F; Michel C; Mitschler A; Arnoult G; Buemi A; Dalle S; Bernard P; Woronoff AS; Grange F
    JAMA Dermatol; 2013 Oct; 149(10):1150-7. PubMed ID: 23945633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients.
    Howman-Giles R; Shaw HM; Scolyer RA; Murali R; Wilmott J; McCarthy SW; Uren RF; Thompson JF
    Ann Surg Oncol; 2010 Jan; 17(1):138-43. PubMed ID: 19672660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
    Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
    Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.
    Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S
    Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States.
    Bilimoria KY; Balch CM; Bentrem DJ; Talamonti MS; Ko CY; Lange JR; Winchester DP; Wayne JD
    Ann Surg Oncol; 2008 Jun; 15(6):1566-76. PubMed ID: 18414952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection.
    Rutkowski P; Nowecki ZI; Zurawski Z; Dziewirski W; Nasierowska-Guttmejer A; Switaj T; Ruka W
    Eur J Cancer; 2006 Jan; 42(2):159-64. PubMed ID: 16324835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Update on current care guidelines: melanoma].
    Duodecim; 2012; 128(9):988-9. PubMed ID: 22667053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.